Company Filing History:
Years Active: 1996-2018
Title: Patrick C May - Innovator in Alzheimer's Disease Research
Introduction
Patrick C May is a notable inventor based in Carmel, IN (US), recognized for his contributions to the field of Alzheimer's disease research. With a total of 4 patents, he has made significant strides in developing therapies aimed at treating cognitive and neurodegenerative diseases.
Latest Patents
One of his latest patents is titled "Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor." This invention provides a method of treating cognitive or neurodegenerative diseases by administering an effective amount of a compound, or a pharmaceutically acceptable salt thereof, in combination with an anti-N3pGlu Abeta monoclonal antibody. Another significant patent is "Methods of inhibiting Alzheimer's Disease," which encompasses methods for inhibiting Alzheimer's Disease by administering an effective amount of a compound of Formula I. This invention also includes methods for increasing TGF-.beta. expression in the brain and inhibiting the .beta.-amyloid peptide mediated neurotoxicity associated with Alzheimer's Disease.
Career Highlights
Patrick C May is currently employed at Eli Lilly and Company, where he continues to innovate and contribute to the advancement of medical treatments. His work focuses on developing effective therapies for Alzheimer's disease, showcasing his commitment to improving patient outcomes.
Collaborations
He collaborates with Dustin James Mergott, working together to enhance research efforts in the field of neurodegenerative diseases.
Conclusion
Patrick C May's innovative work in Alzheimer's disease research highlights his dedication to finding effective treatments for cognitive disorders. His patents reflect a significant contribution to the medical field, aiming to improve the lives of those affected by these challenging conditions.